It was previously confirmed that TERC was amplified in non-small-cell lung carcinoma, and TERC based therapies have the potential function to promote apoptosis of the cancer cells with a high specificity (Gala and Khattar, 2021). The gene discussed is TERC; the disease is non-small cell lung carcinoma.